Information technology services industry
Evofem Biosciences Announces FDA Approval of Phexxi for On-Demand Birth Control
Evofem Biosciences, a commercial-stage biopharmaceutical company, has announced the FDA approval of Phexxi, a non-hormonal, on-demand vaginal pH regulator contraceptive. Phexxi is the first of its kind, designed to maintain vaginal pH within the normal range of 3.5 to 4.5, creating an acidic environment that is inhospitable to